DIKUL - logo
Narodna in univerzitetna knjižnica, Ljubljana (NUK)
Naročanje gradiva za izposojo na dom
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi
  • Modulatorji apoptoze kot nova zdravila
    Vidic, Iztok, 1978 ; Šuput, Dušan ; Milisav, Irina
    Defects in regulation of apoptosis result in a number of human diseases for which there are no adequate medical or pharmacological treatments. Many drug discovery studies have focused on small ... molecular modulators of apoptosis-relevant proteins, like caspases, protein kinases, inhibitors of apoptotic proteins (IAP), Bcl-2 family proteins and others. For example, preclinical studies of reversible caspase-3 inhibitor have shown its potential neuroprotective role in animal models of Huntington disease. An irreversible broad spectrum caspase inhibitor for chronic hepatitis C virus infection is in the phase II clinical trials. An inhibitor of tyrosine kinase involved in the regulation of cell proliferation is being used for the treatment of chronic myeloid leukaemia and some gastrointestinal tumours since2001. Modern drug development strategies involve also the use of antisense mRNA in cancer treatment. Among the most successful is the antisensetargeting of BCL-2, which is currently being reviewed for the approval by the European Medicines Agency. The knowledge about the functions of proteins involved in apoptosis and of their modulators is therefore crucialfor designing new drugs, which promote or suppress apoptosis according to the aetiology of disease.
    Vir: Farmacevtski vestnik : strokovno glasilo slovenske farmacije = pharmaceutical journal of Slovenia. - ISSN 0014-8229 (Letn. 57, št. 2, jul. 2006, str. 150-154)
    Vrsta gradiva - članek, sestavni del
    Leto - 2006
    Jezik - slovenski
    COBISS.SI-ID - 21528025

    Povezava(-e):

    Digitalna knjižnica Slovenije - dLib.si

Vnos na polico